S100A12 Is Associated with Response to Therapy in Juvenile Idiopathic Arthritis.
...Published in The Journal of rheumatology
Responders to MTX or anti-TNF treatment can be identified by higher pretreatment S100A12 serum concentration levels.
Achieving Consensus on Total Joint Replacement Trial Outcome Reporting Using the OMERACT Filter: Endorsement of the Fina...
Published in The Journal of rheumatology
An OMERACT core domain set for hip/knee TJR trials has been defined and we are selecting instruments to develop the TJR clinical trial core measurement set to serve as a common foundation for harmonizing measures in TJR clinical trials.
The OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging (MRI) Scoring System: Updated Recommendations by the OMERACT...
...Published in The Journal of rheumatology
Updated 2016 RAMRIS recommendations and a research agenda were developed.
Introduction.
Published in The Journal of rheumatology
Thoracic Syndesmophytes Commonly Occur in the Absence of Lumbar Syndesmophytes in Ankylosing Spondylitis: A Computed Tom...
Published in The Journal of rheumatology
Syndesmophytes predominate in the thoracic spine. Lumbar radiographs underestimate the degree of thoracic involvement.
Polypharmacy and Unplanned Hospitalizations in Patients with Rheumatoid Arthritis.
Published in The Journal of rheumatology
PP is common in RA and is a prognostic marker associated with increased risk of acute hospitalizations. Our data suggest that PP may be an indicator of comorbidity burden rather than a contributing cause of a drug-related toxicity. PP should be monitored to minimize inappropriate combination of prescribed medications. PP may be a useful predictor o...
IgG4-related Pericoronary Arteritis.
Published in The Journal of rheumatology
Content and Construct Validity, Reliability, and Responsiveness of the Rheumatoid Arthritis Flare Questionnaire: OMERACT...
...Published in The Journal of rheumatology
The RA-FQ has been developed to identify and measure RA flares. Its review through OMERACT Filter 2.0 shows evidence of reliability, content and construct validity, and responsiveness. These properties merit its further validation as an outcome for clinical trials.
The Fascinating Paradox of Osteoporosis in Axial Spondyloarthropathy.
Published in The Journal of rheumatology
Low bone mineral density (BMD) is a recognized feature of axial spondyloarthropathy (axSpA). However, the osteoproliferation inherent in axSpA can make traditional dual-energy x-ray absorptiometry assessment inaccurate, particularly in structurally advanced disease. As a result, much about osteoporosis in axSpA is unknown. There is a wide variation...
Drs. Aggarwal and Oddis reply.
Published in The Journal of rheumatology
